Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association of Age With SARS-CoV-2 Antibody Response

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.4302Source: DataRank Database

Association of Age With SARS-CoV-2 Antibody Response is a research paper published in JAMA Network Open (2021). On theSindex it has a DataRank of 0. It has been cited 258 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access258 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 14.18)OA: goldTopics (69)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Victoria Costa ORCID,Sabrina Racine‐Brzostek ORCID,Karen P. Acker ORCID,Jim Yee ORCID,Zhengming Chen ORCID

Live enrichment

PubMed:33749770 PMC:PMC7985726 OpenAlex:https://openalex.org/W3136275452

NIAID NIH HHS

Grant: R01 AI036082

NIAID NIH HHS

Grant: P01 AI110657

National Institutes of Health

Grant: 2R01AI036082-26A1

Neutralization of Primate Immunodeficiency Viruses

FWCI

14.18

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2777743/yang_2021_oi_210156_1615870841.42258.pdf

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2777743/yang_2021_oi_210156_1615870841.42258.pdf

journalhttps://doi.org/10.1001/jamanetworkopen.2021.4302

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33749770

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7985726

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-190301 basic medicine0303 health sciences03 medical and health sciencesAge FactorsAntibodies, NeutralizingAntibodies, ViralAntibody AffinityAntibody FormationCOVID-19COVID-19 Serological TestingChildCorrelation of DataCross-Sectional StudiesFemaleHumansImmunoglobulin GMaleMiddle AgedNew York CitySARS-CoV-2

MeSH Terms

Correlation of DataCOVID-19SARS-CoV-2COVID-19 Serological TestingAge FactorsAntibodies, ViralAntibody AffinityAntibody FormationChildCross-Sectional StudiesFemaleHumansImmunoglobulin GMaleMiddle AgedNew York CityAntibodies, Neutralizing

Keywords

MedicineAntibodyAvidityYoung adultSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyPediatricsInternal medicineCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)MaleSARS-CoV-2Age FactorsAntibody AffinityCOVID-19Middle AgedAntibodies, ViralAntibodies, NeutralizingCOVID-19 Serological TestingCross-Sectional StudiesImmunoglobulin GAntibody FormationHumansFemaleNew York CityChildCorrelation of DataOriginal Investigation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being